Customers can improve overall accuracy by combining Promega Maxwell® DNA extraction and One Lambda HLA assays

MADISON, Wis.–Promega Corporation, a leading life sciences company, and One Lambda, Inc, a leading producer of transplant diagnostic products, will co-market the Promega Maxwell® 16 DNA extraction system with One Lambda LABType® SSO and Micro SSP™ tests in the HLA market. The combined effort offers clinicians a new option to improve assay accuracy and productivity.

Starting with the American Society for Histocompatability and Immunology (ASHI) show, both companies will be highlighting their complementary technology. Moving forward, the companies will provide integrated programs to clinicians and lab managers who are seeking new options to enhance laboratory productivity.

“Using the Maxwell 16 system helps ensure consistent, reliable results for One Lambda assays, eliminating problems associated with poor sample preparation,” says Dr. Jar-How Lee, One Lambda Vice President of Research and Development. “Suboptimal sample extraction can lead to time-consuming rework and system failure, which slow results, decrease productivity and potentially compromise overall accuracy of the tests.”

The Maxwell 16 System enhances laboratory workflow by automatically extracting DNA from blood, buffy coat or buccal swabs in 30 to 40 minutes. Once extraction is complete, the One Lambda LABType® SSO uses Luminex® xMAP® technology to perform a multiplex analysis on the DNA. Typing results are used in transplantation to match donated tissues to recipients. The analysis dramatically reduces labor, reagents, reaction-to-reaction inconsistency, and assay time when compared with manual methods. Research and customer experience demonstrate that the DNA extracted using Maxwell is of excellent concentration, purity and yield for optimal results from One Lambda LABType® and Micro SSP™ tests.

“We are pleased One Lambda, a leader in transplant diagnostics, has selected Maxwell as its preferred DNA purification tool,” says Promega Marketing Vice President Andy Bertera. “Using these tools together provides clinicians increased performance and, perhaps, a little more peace of mind.”